Media Coverage

December 1, 2009 Dr. Fahar Merchant, President & CEO, Protox therapeutics, presents at the Toronto Board of Trade
February 27, 2009 New shot may be best medicine for prostate cancer - Springfield, MO, KY3 NBC News
October 28, 2008 Dr. Fahar merchant, President & CEO, Protox therapeutics, interviewed on BTV
Mar 26, 2008 Dr. Fahar Merchant, President and CEO, Protox Therapeutics interiewed on BNN Small Caps
Mar 28, 2007 Dr. Fahar Merchant interviewed on BNN
July 1, 2006 Dr. Fahar Mechant featured on Market Matters Radio with host Michael Levy.
Mar 27, 2006 Dr. Fahar Mechant featured on CEO Clips on The Biography Channel
Mar 2, 2006 Cancer Research Institute starts first Phase I clinical trial,
New drug targets prostate cancer cells
Mar 2, 2006 Scott & White interview on CBS
Mar 1, 2006 Scott & White interview on NBC

What's New

December 28, 2011
Protox Therapeutics Announces Closing of Additional CDN $8.3M Investment By Warburg Pincus

December 23, 2011
Protox Therapeutics Announces Additional CDN $8.3M Investment by Warburg Pincus

December 22, 2011
Protox Completes Dosing of Second Cohort of Patients in Transrectal Study

 

 

 

Events

November 17, 2010
- 11:15 am ET
Protox Presents at Dundee Emerging Growth Conference

 

Stock Quote

LAST TRADE:$0.35
TRADE TIME:3:49PM EST
CHANGE:$0.02 (6.06%)
PREV CLOSE: $0.33
OPEN:$0.335
BID:$0.34
ASK:$0.35